CHICAGO - Known as 'the silent killer' due to its lack of symptoms and reliable screening tests, ovarian cancer remains one ...
Company Expects Initial Findings to be presented in 2026-- BOCA RATON, Fla., Dec. 23, 2025 (GLOBE NEWSWIRE) -- LIXTE ...
The updated recommendation expands cervical cancer screening options to include certain FDA-approved self-collection tests.
Guidelines expanded to include self-collection for HPV testing and revised guidance for exiting cervical cancer screening.
Key FDA action dates in early 2026 promise to transform treatment options for solid tumors and rare hematologic malignancies, ...
Hospitals, a large discount store, a Starbucks, a Wawa and an early learning center will be among new locations opening in ...
From annual checkups to life-saving interventions, physicians guide us through every stage of health — offering expertise, ...
Look back at the top 5 updates for oncology nurses and advanced practices providers published in 2025. From clinical updates ...
To see Spark’s full report on AWHL stock, click here.
Abstract: Fallopian tube cancer became clinically meaningful as its biology and pathology resembled ovarian and peritoneal cancers, especially high-grade serous carcinoma. Emerging evidence shows that ...
Veracyte stands out in a pressured medical instruments industry as genAI adoption and rising sales forecasts fuel investor interest.
Research led by a University of Iowa student is opening new doors to potential uterine cancer treatments that could allow patients to regain their health while retaining their ability to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback